We see MLL::AF9 accumulates over the FLT3 and TAPT1 B-ALL-associated target loci in AMLs (Fig. 4b, c), but the levels are below the threshold to be called as oncoprotein-target genes (Supplementary Data 2). This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.